59 Results

People

  1. Van Den Brink
    Van Den Brink
  2. Sadelain
    Sadelain
  3. Scheinberg
    Scheinberg
  4. Kochman
    Kochman
  5. Perales
    Perales
  6. Alpdogan
    Alpdogan
  7. Young
    Young
  8. Hubbard
    Hubbard
  9. O'Reilly
    O'Reilly
  10. Lu
    Lu

Groups

  1. Center for Hematologic Malignancies (59)
  2. Department of Medicine (59)
  3. GSK Faculty (59)
  4. Hematologic Malignancies, Division of (55)
  5. Sloan Kettering Institute Faculty (53)
  6. Hematologic Malignancies Research (33)
  7. Immunology Program Faculty (30)
  8. Molecular Pharmacology and Chemistry Program Faculty (29)
  9. Bone Marrow Transplant (18)
  10. Executive Committee, Center for Hematologic Malignancies (18)
  1. "Center for Hematologic Malignancies"
  2. "GSK Faculty"
  3. "2006"
  4. "Department of Medicine"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (26)
Groups
  1. Center for Hematologic Malignancies (59)
  2. Department of Medicine (59)
  3. GSK Faculty (59)
  4. Hematologic Malignancies, Division of (55)
  5. Sloan Kettering Institute Faculty (53)
  6. Hematologic Malignancies Research (33)

More Groups

People
  1. Marcel Van Den Brink (18)
  2. Michel Sadelain (14)
  3. David Scheinberg (13)
  4. Adam Kochman (11)
  5. Miguel-Angel Perales (11)
  6. James Young (10)

More People

Years
  1. 2006 (59)
Publications
  1. Blood (18)
  2. Biology of Blood and Marrow Transplantation (7)
  3. Journal of Clinical Oncology (4)
  4. Journal of Immunology (4)
  5. Cancer Biotherapy and Radiopharmaceuticals (2)
  6. Cytotherapy (2)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Elsevier Inc. (9)
  3. Nature Publishing Group (6)
  4. American Society of Clinical Oncology (4)
  5. The American Association of Immunologists, Inc (4)
  6. Mary Ann Liebert, Inc (3)

More Publishers

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The inhibitory Fc gamma-receptor IIB (CD32B) is highly expressed on clonal plasma cells from patients with systemic light-chain (AL) amyloidosis and provides a target for monoclonal antibody therapy
    Meeting Abstract

    Zhou, P.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Fleisher, M.; Young, J.; Boruchov, A.; Comenzo, R. L.
    Amyloid (2006)

    Fulltext@MSK | Save
  • Adoptive transfer of in vitro generated T cell precursors improves T cell reconstitution and mediates graft-versus-tumor activity without graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients
    Meeting Abstract

    Zakrzewski, J. L.; Kochman, A. A.; Lu, S. X.; Terwey, T.; Kim, T. D.; Hubbard, V. M.; Muriglan, S. J.; Suh, D.; Cabrera-Perez, J.; Heller, G.; more...
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Human natural killer cells achieve tolerance by preferentially endowing functional competence to inhibitory killer Ig-like receptors specific for self-HLA class I
    Meeting Abstract

    Yu, J.; Pinto-Agnello, C.; Chewning, J.; Hsu, K. C.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of rituximab for the prevention of Epstein Barr virus B cell lymphoproliferative disorder (EBV-LPD) following T cell depleted (TCD) unrela ted or HLA-mismatched related hematopoietic stem cell transplantation
    Meeting Abstract

    Small, T. N.; Kernan, N. A.; Jakubowski, A.; Young, J. W.; Prockop, S.; Perales, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.
    Blood (2006)

    Fulltext@MSK | Save
  • Relative biological effectiveness for efficacy and toxicity in leukemia patients of the alpha-particle emitter, bismuth-213
    Meeting Abstract

    Sgouros, G.; Bolch, W. E.; Shah, A.; Watchman, C. J.; Jurcic, J. G.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Treatment outcome after induction chemotherapy before allogeneic hematopoietic SCT in patients with advanced MDS
    Meeting Abstract

    Ramos, C. A.; Jakubowski, A. A.; Boulad, F.; Papadopoulos, E. B.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Berman, E.; O'Reilly, R. J.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Immunogenicity of haemophilus influenza and pneumococcal vaccines in related and unrelated transplant recipients
    Meeting Abstract

    Pao, M. K.; Papadopoulos, E. B.; Kernan, N. A.; Jakubowski, A. A.; Young, J. W.; Castro-Malaspina, H. R.; Perales, M. A.; O'Reilly, R. J.; Boulad, F.; Prockop, S.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • CD4+peptide epitopes from the WT1 oncoprotein stimulate CD4+and CD8+T cells that recognize and kill leukemia and solid tumor cells
    Meeting Abstract

    May, R. J.; Pinilla, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Dao, T.; Maslak, P.; Scheinberg, D. A.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • LRF/Pokemon plays a pivotal role in B versus T lymphoid lineage fate decision at the early lymphoid progenitor stage by opposing Notch1 signaling
    Meeting Abstract

    Maeda, T.; Merghoub, T.; Dong, L.; Maeda, M.; Hobbs, R.; Zakrzewski, J.; Van Den Brink, M.; Shigematsu, H.; Akashi, K.; Zelent, A.; more...
    Blood (2006)

    Fulltext@MSK | Save